These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 7128699

  • 1. Is TL-99 a selective presynaptic dopamine receptor agonist?
    Horn AS, De Vries J, Dijkstra D, Mulder AH.
    Eur J Pharmacol; 1982 Sep 10; 83(1-2):35-45. PubMed ID: 7128699
    [Abstract] [Full Text] [Related]

  • 2. The purported dopamine agonist DPI inhibits [3H]noradrenaline release from rat cortical slices but not [3H]dopamine and [14C]acetylcholine release from rat striatal slices in-vitro.
    Van Oene JC, Sminia P, Mulder AH, Horn AS.
    J Pharm Pharmacol; 1983 Dec 10; 35(12):786-92. PubMed ID: 6141240
    [Abstract] [Full Text] [Related]

  • 3. Interaction of the component enantiomers of the putative dopamine autoreceptor agonist, TL-99 (6,7-dihydroxy-2-dimethylamino tetralin) with dopaminergic systems in mammalian brain and teleost retina.
    Williams M, Martin GE, McClure DE, Baldwin JJ, Watling KJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec 10; 324(4):275-80. PubMed ID: 6141532
    [Abstract] [Full Text] [Related]

  • 4. Further in vitro and in vivo studies with the putative presynaptic dopamine agonist N,N-dipropyl-7-hydroxy-2-aminotetralin.
    Mulder TB, de Vries JB, Dijkstra D, Wiechers JW, Grol CJ, Horn AS.
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov 10; 336(5):494-501. PubMed ID: 2830544
    [Abstract] [Full Text] [Related]

  • 5. Postsynaptic dopamine agonist properties of TL-99 are revealed by yohimbine co-treatment.
    Pastor G, Fallon S, Welch JJ, Liebman JM.
    Eur J Pharmacol; 1983 Mar 04; 87(4):459-64. PubMed ID: 6303801
    [Abstract] [Full Text] [Related]

  • 6. N-0437: a selective D-2 dopamine receptor agonist in in vitro and in vivo models.
    Van der Weide J, De Vries JB, Tepper PG, Krause DN, Dubocovich ML, Horn AS.
    Eur J Pharmacol; 1988 Mar 01; 147(2):249-58. PubMed ID: 3130270
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological profiles of three new, potent and selective dopamine receptor agonists: N-0434, N-0437 and N-0734.
    Van der Weide J, De Vries JB, Tepper PG, Horn AS.
    Eur J Pharmacol; 1986 Jun 17; 125(2):273-82. PubMed ID: 3743637
    [Abstract] [Full Text] [Related]

  • 8. The enantiomers of the D-2 dopamine receptor agonist N-0437 discriminate between pre- and postsynaptic dopamine receptors.
    Van der Weide J, Tendijck ME, Tepper PG, De Vries JB, Dubocovich ML, Horn AS.
    Eur J Pharmacol; 1988 Feb 09; 146(2-3):319-26. PubMed ID: 2836210
    [Abstract] [Full Text] [Related]

  • 9. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.
    Claustre Y, Fage D, Zivkovic B, Scatton B.
    J Pharmacol Exp Ther; 1985 Feb 09; 232(2):519-25. PubMed ID: 2857197
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological profile of N,N dipropyl-8-hydroxy-3-chromanamine, an oxygen isostere of the dopamine agonist N,N dipropyl-5-hydroxy-2-aminotetralin with enhanced presynaptic selectivity.
    Vermue NA, Kaptein B, Tepper PG, de Vries JB, Horn AS.
    Arch Int Pharmacodyn Ther; 1988 Feb 09; 293():37-56. PubMed ID: 3421784
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological profiles of the putative dopamine autoreceptor agonists 3-PPP and TL-99.
    Martin GE, Haubrich DR, Williams M.
    Eur J Pharmacol; 1981 Nov 19; 76(1):15-23. PubMed ID: 7318920
    [Abstract] [Full Text] [Related]

  • 12. Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
    Seiler MP, Markstein R.
    Mol Pharmacol; 1984 Nov 19; 26(3):452-7. PubMed ID: 6238231
    [Abstract] [Full Text] [Related]

  • 13. Involvement of both dopaminergic and alpha-adrenergic receptors in the hypomotility induced by dibenzoyl-6,7-ADTN.
    Sumners C, De Vries JB, Dijkstra D, Horn AS.
    Eur J Pharmacol; 1981 Apr 09; 70(4):541-50. PubMed ID: 6113149
    [Abstract] [Full Text] [Related]

  • 14. Resolved cis- and trans-2-amino-5-methoxy-1-methyltetralins: central dopamine receptor agonists and antagonists.
    Johansson AM, Arvidsson LE, Hacksell U, Nilsson JL, Svensson K, Carlsson A.
    J Med Chem; 1987 Apr 09; 30(4):602-11. PubMed ID: 3560156
    [Abstract] [Full Text] [Related]

  • 15. N-methyl,N-propargyl-2-aminotetralins:novel dopamine agonists with monoamine oxidase inhibiting properties.
    Hazelhoff B, De Vries JB, Dijkstra D, Mulder TB, Horn AS.
    Eur J Pharmacol; 1985 Feb 26; 109(2):229-40. PubMed ID: 3922776
    [Abstract] [Full Text] [Related]

  • 16. Agonist and antagonist effects of 3-PPP enantiomers on functional dopamine autoreceptors and postsynaptic dopamine receptors in vitro.
    Mulder AH, Draper R, Sminia P, Schoffelmeer AN, Stoof JC.
    Eur J Pharmacol; 1985 Jan 08; 107(3):291-7. PubMed ID: 3979429
    [Abstract] [Full Text] [Related]

  • 17. Evidence that the purported dopaminergic agonist (3,4-dihydroxyphenylimino)-2-imidazolidine (DPI) may reduce rat striatal dopamine turnover by an alpha 2-adrenergic mechanism.
    van Oene JC, Houwing HA, Horn AS.
    Eur J Pharmacol; 1982 Jun 16; 81(1):75-87. PubMed ID: 6126370
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of striatal dopamine release by the selective D-2 dopamine receptor agonist N-0437 is blocked by quinine.
    Cass WA, Zahniser NR.
    Synapse; 1990 Jun 16; 5(4):336-7. PubMed ID: 2141733
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacological profile of a chromanamine analogue (DP-6OH-3CA) of the selective presynaptic dopamine agonist N,N-dipropyl-7-hydroxy-2-aminotetralin.
    Vermue NA, Dijkstra D, Horn AS.
    J Pharm Pharmacol; 1988 Aug 16; 40(8):574-7. PubMed ID: 2907015
    [Abstract] [Full Text] [Related]

  • 20. ACTH-(1-24) and alpha-MSH antagonize dopamine receptor-mediated inhibition of striatal dopamine and acetylcholine release.
    Versteeg DH, De Crom MP, Mulder AH.
    Life Sci; 1986 Mar 03; 38(9):835-40. PubMed ID: 3005796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.